Faculty of Health Sciences
School of Medicine
Department of Haematology
Non-inferiority efficacy trial comparing prophylaxis treatment with BAY81-8973
A two-part, randomized, cross-over, open-label trial to evaluate the pharmacokinetics, efficacy and safety profile of plasma protein-free recombinant FVIII formulated with sucrose (BAY 81-8973) in previously treated subjects with severe Haemophilia-A under prophylaxis therapy
|
